AWM Investment Company Inc. Boosts Holdings in OrthoPediatrics Corp. (NASDAQ:KIDS)

AWM Investment Company Inc. grew its stake in shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 14.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 516,794 shares of the company's stock after purchasing an additional 66,779 shares during the period. AWM Investment Company Inc. owned approximately 2.13% of OrthoPediatrics worth $11,979,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in KIDS. Wellington Management Group LLP raised its stake in shares of OrthoPediatrics by 20.2% during the 4th quarter. Wellington Management Group LLP now owns 1,061,299 shares of the company's stock worth $24,601,000 after buying an additional 178,078 shares during the last quarter. Wasatch Advisors LP raised its stake in shares of OrthoPediatrics by 47.2% during the 4th quarter. Wasatch Advisors LP now owns 696,318 shares of the company's stock worth $16,141,000 after buying an additional 223,217 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of OrthoPediatrics by 29.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 671,968 shares of the company's stock worth $15,576,000 after buying an additional 152,681 shares during the last quarter. Millennium Management LLC acquired a new position in shares of OrthoPediatrics during the 4th quarter worth $9,798,000. Finally, Point72 Asset Management L.P. acquired a new position in shares of OrthoPediatrics during the 4th quarter worth $7,450,000. 69.05% of the stock is currently owned by hedge funds and other institutional investors.

OrthoPediatrics Price Performance

KIDS stock traded down $0.32 during trading on Friday, hitting $20.83. The stock had a trading volume of 72,124 shares, compared to its average volume of 196,497. The company's 50 day moving average price is $22.54 and its two-hundred day moving average price is $23.78. OrthoPediatrics Corp. has a 1-year low of $20.25 and a 1-year high of $35.99. The stock has a market cap of $505.90 million, a price-to-earnings ratio of -16.93 and a beta of 1.09. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported ($0.39) earnings per share for the quarter, missing the consensus estimate of ($0.26) by ($0.13). OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. The firm had revenue of $52.41 million during the quarter, compared to analyst estimates of $51.68 million. On average, sell-side analysts forecast that OrthoPediatrics Corp. will post -0.93 EPS for the current fiscal year.

Wall Street Analyst Weigh In

KIDS has been the subject of several research reports. Needham & Company LLC reaffirmed a "buy" rating and set a $42.00 price target on shares of OrthoPediatrics in a research note on Thursday, May 8th. Piper Sandler cut their price target on OrthoPediatrics from $40.00 to $30.00 and set an "overweight" rating for the company in a research note on Thursday, May 8th. Lake Street Capital initiated coverage on OrthoPediatrics in a research note on Monday, April 7th. They set a "buy" rating and a $37.00 price target for the company. Truist Financial cut their price target on OrthoPediatrics from $26.00 to $24.00 and set a "hold" rating for the company in a research note on Friday, April 11th. Finally, Stifel Nicolaus cut their price target on OrthoPediatrics from $40.00 to $32.00 and set a "buy" rating for the company in a research note on Wednesday, March 5th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $35.83.

Insider Activity at OrthoPediatrics

In related news, CEO David R. Bailey sold 6,620 shares of the business's stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total value of $164,573.20. Following the completion of the transaction, the chief executive officer now owns 319,155 shares of the company's stock, valued at approximately $7,934,193.30. The trade was a 2.03% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Fred Hite sold 6,443 shares of OrthoPediatrics stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total value of $160,172.98. Following the completion of the sale, the chief financial officer now owns 207,989 shares of the company's stock, valued at $5,170,606.54. This trade represents a 3.00% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 23,732 shares of company stock valued at $589,978. 32.70% of the stock is owned by insiders.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.